Sort   by:  
 Page size 
UnknownPersonalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.
Not available
S-EPMC10647159 | biostudies-literature
UnknownCarboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01).
Not available
S-EPMC8740214 | biostudies-literature
UnknownA randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG.
Not available
S-EPMC4433520 | biostudies-literature
UnknownImpact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
Not available
S-EPMC8052935 | biostudies-literature
UnknownPredictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial.
Not available
S-EPMC11357803 | biostudies-literature
UnknownDifferential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments.
Not available
S-EPMC9377758 | biostudies-literature
UnknownFasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.
Not available
S-EPMC7311547 | biostudies-literature
UnknownImplementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020-2023, using registry data and questionnaires.
Not available
S-EPMC12164123 | biostudies-literature
Sort   by:  
 Page size